Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Neuer Top-Geologe an Bord - zündet jetzt die nächste Kursrakete?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
252 Leser
Artikel bewerten:
(0)

Abbott Voluntarily Recalls Certain Similac Brand Powder Infant Formulas That Did Not Meet Its Quality Standards

ABBOTT PARK, Ill., Sept. 22 /PRNewswire/ -- Abbott is initiating a proactive, voluntary recall of certain Similac-brand, powder infant formulas in the U.S., Puerto Rico, Guam and some countries in the Caribbean.

(Photo: http://photos.prnewswire.com/prnh/20100922/CG69635) (Photo: http://www.newscom.com/cgi-bin/prnh/20100922/CG69635)

Abbott is recalling these products following an internal quality review, which detected the remote possibility of the presence of a small common beetle in the product produced in one production area in a single manufacturing facility. The United States Food and Drug Administration (FDA) has determined that while the formula containing these beetles poses no immediate health risk, there is a possibility that infants who consume formula containing the beetles or their larvae, could experience symptoms of gastrointestinal discomfort and refusal to eat as a result of small insect parts irritating the GI tract. If these symptoms persist for more than a few days, a physician should be consulted.

The recall of these powder infant formulas includes: -- Certain Similac powder product lines offered in plastic containers. -- Certain Similac powder product lines offered in sizes such as 8-ounce, 12.4-ounce and 12.9-ounce cans.

To immediately find out if the product in your possession is included in this recall, parents and caregivers should visit http://www.similac.com/recall, and type in their lot number to determine if their product is affected, or call (800) 986-8850.

No Abbott liquid infant formulas are impacted. Products not involved in the recall include all Abbott Nutrition liquid ready-to-feed and concentrated infant formulas and all powder and liquid specialty formulas, such as Similac Expert Care(TM) Alimentum®, Elecare®, Similac Expert Care(TM) Neosure®, Similac® Human Milk Fortifier, and metabolic formulas for inherited disorders.

About the Recall -- The company is implementing a plan to address this matter in the affected manufacturing facility, which is expected to be completed shortly. No other facilities or products are involved in this recall. -- Abbott has consulted with the U.S. FDA regarding this recall. Information for Parents and Caregivers -- Products with affected lot numbers should be returned to Abbott at no cost to the consumer. -- Parents and caregivers can go to http://www.similac.com/recall or call Abbott's consumer hotline, (800) 986-8850, 24 hours a day, seven days a week. -- Both the website and the consumer hotline have specific details on how to complete the return process. Holger Liepmann, executive vice president, Abbott Nutrition said:

"Abbott understands that parents expect to feed their children only the highest quality product. We are taking this action so that parents know that the infant formula products they provide unquestionably meet the highest quality standards for which they are known. We regret any inconvenience this situation poses to parents and consumers."

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's website at http://www.abbott.com/.

Photo: http://photos.prnewswire.com/prnh/20100922/CG69635
http://www.newscom.com/cgi-bin/prnh/20100922/CG69635
PRN Photo Desk, photodesk@prnewswire.com

Abbott

CONTACT: Media, Jennifer Smoter, +1-847-935-8865, or Melissa Brotz,
+1-847-935-3456, or Kelly Morrison, +1-847-937-3802, or Spanish Speaking
Media, Raquel Powers, +1-847-936-1192, or Financial, Larry Peepo,
+1-847-935-6722, or Consumer Hotline, 1-800-986-8850, all of Abbott

Web Site: http://www.abbott.com/

© 2010 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.